8.3.1 Hormone responsive prostate cancer

NICE NG131: Prostate cancer: diagnosis and management

All GnRH analogues are equally effective and specialists will continue to recommend treatment with a 'GnRH analogue' rather than a specific brand of product unless clinically indicated.
Specialists agree that GPs can change the product prescribed within this class of therapy to complete courses of therapy for existing patients as clinically appropriate and after informed discussions with the patient.

  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs with Shared Care Guidelines
  • Specialist Only Drugs
  • Mixed Status